Lisata Therapeutics
LSTA
32 hedge funds and large institutions have $3.37M invested in Lisata Therapeutics in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
38% more capital invested
Capital invested by funds: $2.44M → $3.37M (+$933K)
33% more funds holding
Funds holding: 24 → 32 (+8)
0.07% more ownership
Funds ownership: 0.59% → 0.66% (+0.07%)
70% less call options, than puts
Call options by funds: $170K | Put options by funds: $558K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$202K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$180K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
| 4 |
Renaissance Technologies
New York
|
+$144K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$134K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$19K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$7.02K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Jane Street
New York
| – | -$19K | -719 | Closed |
|
27
Wells Fargo
San Francisco,
California
| – | +$95 | +3 | +75% |
|
|
CG
28
Cutler Group
San Francisco,
California
| – | +$854 | +27 | New |
|
LSTA Hedge Fund Activity: Q3 2020 in Review
32 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q3 2020, worth a combined $3.37M — up 38% from $2.44M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new LSTA positions and 1 closed out — a net gain of 8 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $202K. The largest seller was Jane Street, exiting entirely with an estimated $19K sold.
- 32 institutional investors held Lisata Therapeutics (LSTA) as of Q3 2020, up from 24 in Q2 2020.
- Funds reported $3.37M of Lisata Therapeutics stock for Q3 2020, up 38% quarter-over-quarter.
- 9 funds opened new Lisata Therapeutics positions in Q3 2020 and 1 closed out, a net change of +8 holders.
- The largest Lisata Therapeutics buyer in Q3 2020 was Sabby Management, an estimated $202K added.
- The largest Lisata Therapeutics seller in Q3 2020 was Jane Street, an estimated $19K sold.
Based on aggregated 13F filings for Q3 2020.